Dr. Mark M Moasser M.D.
Oncologist | Medical Oncology
1600 Divisadero St 2nd Floor, Box 1710 San Francisco CA, 94115About
Dr. Mark Moasser is a medical oncologist specializing in breast cancer treatment and research. In the laboratory, he works to develop more effective therapies for the treatment of breast cancer and designs ...
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Inhibition of heat shock protein 90 function by ansamycins causes the morphological and functional differentiation of breast cancer cells.
- Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial.
- The tyrosine kinase inhibitor ZD1839 ("Iressa") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells.
- The use of molecular markers in farnesyltransferase inhibitor (FTI) therapy of breast cancer.
- A novel pyridopyrimidine inhibitor of abl kinase is a picomolar inhibitor of Bcr-abl-driven K562 cells and is effective against STI571-resistant Bcr-abl mutants.
- Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling.
- S-phase inhibition of cell cycle progression by a novel class of pyridopyrimidine tyrosine kinase inhibitors.
- Adhesion signaling by a novel mitotic substrate of src kinases.
- Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3.
- The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis.
- Targeting the function of the HER2 oncogene in human cancer therapeutics.
- Targeting HER proteins in cancer therapy and the role of the non-target HER3.
- Improved tumor vascular function following high-dose epidermal growth factor receptor tyrosine kinase inhibitor therapy.
- The HER family and cancer: emerging molecular mechanisms and therapeutic targets.
- The epidermal growth factor receptor family: biology driving targeted therapeutics.
Clinical Trials
Fellowships
- Memorial Sloan - Kettering Cancer Center 1995
Dr. Mark M Moasser M.D.'s Practice location
Dr. Mark M Moasser M.D.'s reviews
Write ReviewPatient Experience with Dr. Moasser
Recommended Articles
- Nodular Melanoma Symptoms
What is nodular melanoma?Nodular melanoma is one of the five subgroups of melanoma. It usually develops in the cells of the skin that produce the pigment called melanin, which gives the skin its color. Approximately 15 percent of melanoma cases are nodular melanoma and is the most aggressive...
- Estrogen Modulator for Breast Cancer
Hormone Receptor Breast CancerThere are certain types of breast cancer that are mostly affected by the hormones that are produced by the body. They are known as ER positive and PR positive breast cancer cells. These cells have receptors that are attached to the estrogen in the body. This estrogen...
- What are the Signs and Symptoms of Testicular Cancer?
Cancer is an unhealthy condition in which the cells of a part of the body rapidly divide and thrive without an apparent cause. These abnormally growing germ cells clump together, forming a buildup of tissue called a tumor that sets it apart from normal healthy tissue. When this happens in the...
- Ovarian Cancer: Why Do I Need a Hysterectomy?
Ovarian cancer is one of the most common cancers in women. Known to rapidly grow, the cancer can progress from early to advanced stages within a year. Therefore, many a times, the patient reaches the doctor only at the very end.To be diagnosed with ovarian cancer means that you are at a very high...
- How to Support a Loved One Who Has Breast Cancer
So someone you know has breast cancer. Now what? Letting her know that you love her and you’ll pray for her and will be there to help her through it all may sound like a cliché, but what else can you do? What can you say that will make it better for her? What does she need? You won’t find out...
- Don't Call Them Just Survivors; They Are "Overcomers"
It’s common to throw the word "survivor" thrown around when referring to people who have battled illnesses and diseases. However, a group in San Antonio prefers to refer to themselves as Overcomers.Genny's storyWhen Genny Small was diagnosed with breast cancer, she could not believe it. She...
Nearby Providers
- Dr. John W Park MD1600 Divisadero St San Francisco CA 94115
- Dr. Bertrand Y Tuan M.D.2100 WEBSTER ST STE 225 SAN FRANCISCO CA 94115
- Dr. Hope S. Rugo MD1600 Divisadero St San Francisco CA 94115
- Dr. Thierry M. Jahan MD1600 Divisadero St San Francisco CA 94115
- Dr. Alan M Kramer MD2100 Webster St San Francisco CA 94115
- Dr. Alan B Newman MD2100 Webster Street San Francisco CA 94115